Dr Reddy's Laboratories Q1 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,210.85
-13.05 (-1.07%)
-13.05 (-1.07%)Volume87.32 K
Updated: Fri 17 Jul, 2026 | 15:51:21
NSE
1,211.20-13.20 (-1.08%)
-13.20 (-1.08%)Volume2.08 M
Updated: Fri 17 Jul, 2026 | 15:49:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Dr Reddy's Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6,874.60 | 7,721.00 | -1.01% | 5,946.80 | 15.60% |
| Depreciation/ Amortization | 476.10 | 557.10 | 4.71% | 380.60 | 25.09% |
| Operating Income | 1,697.50 | -,174.60 | 7.19% | 1,749.30 | -2.96% |
| Net Income | 1,418.10 | 220.90 | -11.00% | 1,392.40 | 1.85% |
| Other Operating Expenses Total | 2,087.50 | 2,246.90 | -3.47% | - | N/A |
| Net Income Before Taxes | 1,905.00 | 199.70 | -5.00% | 1,882.60 | 1.19% |
| Total Revenue | 8,572.10 | 7,546.40 | 0.51% | 7,696.10 | 11.38% |
| Selling/ General/ Admin Expenses Total | 1,503.50 | 1,446.80 | 7.35% | 3,384.00 | -55.57% |
| Diluted Normalized EPS | 17.02 | 4.66 | -14.18% | 16.70 | 1.91% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.